| 000 | 02565nam a2200301Ia 4500 | ||
|---|---|---|---|
| 003 | MX-MdCICY | ||
| 005 | 20250626080925.0 | ||
| 040 | _cCICY | ||
| 090 | _aB-18859 | ||
| 245 | 1 | 0 | _aHarnessing nanomaterials for copper-induced cell death |
| 490 | 0 | _aBiomaterials, 313, p.122805, 2025 | |
| 500 | _aArtÃculo | ||
| 520 | 3 | _aCopper (Cu), an essential micronutrient with redox properties, plays a pivotal role in a wide array of pathological and physiological processes across virtually all cell types. Maintaining an optimal copper concentration is critical for cellular survival: insufficient copper levels disrupt respiration and metabolism, while excess copper compromises cell viability, potentially leading to cell death. Similarly, in the context of cancer, copper exhibits a dual role: appropriate amount of copper can promote tumor progression and be an accomplice, yet beyond befitting level, copper can bring about multiple types of cell death, including autophagy, apoptosis, ferroptosis, immunogenic cell death, pyroptosis, and cuproptosis. These forms of cell death are beneficial against cancer progression; however, achieving precise copper regulation within tumors remains a significant challenge in the pursuit of effective cancer therapies. The emergence of nanodrug delivery systems, distinguished by their precise targeting, controlled release, high payload capacity, and the ability to co-deliver multiple agents, has revitalized interest in exploiting copper's precise regulatory capabilities. Nevertheless, there remains a dearth of comprehensive review of copper's bidirectional effects on tumorigenesis and the role of copper-based nanomaterials in modulating tumor progression. This paper aims to address this gap by elucidating the complex role in cancer biology and highlighting its potential as a therapeutic target. Through an exploration of copper's dualistic nature and the application of nanotechnology, this review seeks to offer novel insights and guide future research in advancing cancer treatment. | |
| 650 | 1 | 4 | _aCOPPER |
| 650 | 1 | 4 | _aNANOMATERIALS |
| 650 | 1 | 4 | _aCANCER |
| 650 | 1 | 4 | _aCELL DEATH |
| 650 | 1 | 4 | _aCUPROPTOSIS |
| 650 | 1 | 4 | _aCANCER THERAPY |
| 700 | 1 | 2 | _aLi, S. R. |
| 700 | 1 | 2 | _aTao, S. Y. |
| 700 | 1 | 2 | _aLi, Q. |
| 700 | 1 | 2 | _aHu, C. Y. |
| 700 | 1 | 2 | _aSun, Z. J. |
| 856 | 4 | 0 |
_uhttps://drive.google.com/file/d/1RyagmVcGCb487BZLcuEU-I5K8ZhK2BBj/view?usp=drive_link _zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx |
| 942 |
_2Loc _cREF1 |
||
| 008 | 250602s9999 xx |||||s2 |||| ||und|d | ||
| 999 |
_c55556 _d55556 |
||